Page 89 - 2021年18期
P. 89

insertion of the double-lumen tracheal tube,group L was given aerosol inhalation of Lidocaine hydrochloride injection 1.5 mg/kg
        diluted to 20 mL with sterile water;group N was given aerosol inhalation of sterile water 20 mL at the flow rate of 2 L/min.
        Patients in both groups were continuously pumped with Propofol injectable emulsion 4-12 mg/(kg·h)+Remifentanil hydrochloride
        for injection 0.2-1 μg/(kg·min)+Cisatracurium besilate for injection 0.05-0.1 mg/(kg·h)for anesthesia maintenance. Eight hours
        after operation,group L inhaled of Lidocaine hydrochloride injection 1.5 mg/kg diluted to 20 mL with sterile water again,and
        group N inhaled of sterile water 20 mL again. Arterial blood gas analysis indexes [arterial partial pressure of oxygen(PaO2 ),partial
        pressure of carbon dioxide (PaCO2 ),lactic acid (Lac),oxygenation index (P/F)],serum inflammatory factors [interleukin 6
       (IL-6),tumor necrosis factor α(TNF-α)and nuclear factor κB(NF-κB)] were observed in 2 groups before anesthesia(T 1 ),60
        min of one-lung ventilation(T 2 ),and 12 h after extubation(T 3 ). Respiratory and circulatory parameters [extravascular lung
        water(EVLW),pulmonary vascular permeability index(PVPI),heart rate(HR),stroke volume(SV)] were also observed 5 min
        after anesthesia (t1 ),T2 and 15 min after surgery (t3 ). Extubation time,visual analogue scale (VAS) score of 12 h after
        extubation,time of getting out of bed,the incidence of throat pain of 12 h after extubation and the occurrence of ADR were
        recorded in 2 groups. RESULTS:There was no significant difference in arterial blood gas analysis indexes,serum inflammatory
        factor levels,respiratory and circulatory parameters between the two groups at T1 or t1(P>0.05). The levels of PaO2,PaCO2,
        Lac,IL-6,TNF-α and NF-κB in 2 groups at T2 and T3 were significantly higher than at T1,P/F at T2 and T3 was significantly lower
        than at T1;in group L,the levels of PaCO2,Lac,IL-6,TNF-α,NF-κB were significantly lower than group N,and PaO2 and P/F
        were significantly higher than group N(P<0.05). EVLW and PVPI of 2 groups at T2 and t3,SV of group L,HR of group N were
        significantly higher than corresponding group at T1,while EVLW,PVPI and HR of group L were significantly lower than group
        N,SV was significantly higher than group N at corresponding period(P<0.05). The extubation time,VAS score of 12 h after
        extubation,time to get out of bed after surgery,the incidence of throat pain of 12 h after extubation in group L were significantly
        shorter or lower than group N(P<0.05). No obvious and serious ADR occurred during recovery. CONCLUSIONS:Lidocaine
        aerosol inhalation can effectively improve ventilation and oxygenation function of patients undergoing one-lung ventilation,inhibit
        the release of inflammatory factors,and reduce the incidence of postoperative complications with good safety.
        KEYWORDS     Lidocaine;Aerosol inhalation;One-lung ventilation;Postoperative period;Pulmonary function;Inflammatory
        factors;Complication


            单肺通气(one-lung ventilation,OLV)主要用于胸科           或肺泡,使药物持续作用于肺泡上皮或血管内皮等靶器
        手术,是一种能为外科医师提供足够视野及操作空间,                           官,从而达到治疗呼吸道疾病的目的的一种给药方式。
        同时将两肺充分隔离以防止交叉感染或降低肺部肿瘤                            由于雾化吸入的作用位置较集中、作用时间亦相对可
                                                                                                      [8]
        种植传播风险的麻醉技术。但在临床应用中发现,该技                           控,因此可减轻药物对全身组织器官功能的影响 。目
        术可引发急性肺损伤(包括呼吸机相关性肺损伤)、术后                          前,虽然已有研究将雾化吸入利多卡因用于外科手术

        肺部炎症、低氧血症以及因肺缺血再灌注损伤所导致的                           (如耳鼻喉科手术、双腔支气管插管及甲状腺术)麻
                                  [1]
        急性呼吸窘迫综合征等并发症 。                                    醉  [9-11] ,但用于 OLV 患者的报道甚少。为此,本研究探
            利多卡因作为钠离子通道阻滞药,不仅具有局部神                         讨了利多卡因雾化吸入对 OLV 患者肺功能及炎症因子
        经阻滞(局部麻醉)的作用,而且还具有抗心律失常的活                          的影响,旨在为临床用药提供参考。
                                   [2]
        性,同时该药也是一种膜稳定剂 。有研究表明,利多卡                          1 资料与方法
        因能通过抑制炎症反应来改善OLV患者的肺部损伤,具                          1.1 纳入与排除标准
        有类似抗炎剂的作用 。静脉注射利多卡因可减轻胸科                               纳入标准包括:(1)美国麻醉医师协会分级Ⅰ~Ⅱ
                          [3]
        手术患者术后疼痛程度、降低术后肺部并发症的发生风                           级;(2)术前未接受放化疗及激素疗法等治疗手段;(3)
        险、抑制机体炎症反应,具有减轻肺损伤的作用                     [4-5] ,但  无明显肝肾功能异常;(4)美国纽约心脏病学会心功能
        由于该药静脉使用易出现中毒反应,如嗜睡、口周麻木、                          分级Ⅰ~Ⅱ级,心脏节律无明显异常;(5)术前无肺部感
        耳鸣震颤等,若用药不当则可致血药浓度过高,从而引                           染或感染经治愈后1周以上;(6)肺功能正常或轻度通气
        起严重心律失常,甚至心脏骤停              [2,4] ,因此其临床应用受        功能障碍;(7)具有完全自主决策能力,拟在胸腔镜下行
        到了一定的限制       [6-7] 。                              肺部分切除术的患者。
            雾化吸入是通过特定装置利用高速气体将药物转                              排除标准包括:(1)合并糖尿病、高血压等慢性病且
        化为气溶胶颗粒的形式,经上下呼吸道送至各级支气管                           未经规范治疗者;(2)房室传导阻滞、左右束支传导异常


        中国药房    2021年第32卷第18期                                            China Pharmacy 2021 Vol. 32 No. 18  ·2255 ·
   84   85   86   87   88   89   90   91   92   93   94